Recombinant IL-2 Shows Potential in Atopic Dermatitis
"This is the first study to demonstrate the therapeutic potential of rezpegaldesleukin," said Jonathan Silverberg, MD, PhD, MPH, who presented results of a phase 1b study.
Source: medscape.com
Page 2 - Sol 2 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Sol 2. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Sol 2 Today - Breaking & Trending Today
EQS-News: Befesa S.A.: Einladung zur Hauptversammlung am 15. Juni 2023
EQS-News: Befesa S.A. / Schlagwort(e): Hauptversammlung Befesa S.A.: Einladung zur Hauptversammlung am 15. Juni 2023 12.05.2023 / 12:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. BEFESA Befesa S.A. société anonyme 68-70, Boulevard de la Pétrusse, L-2...
Source: boersennews.de
USCIS Biometrics Requirement for Nonimmigrant Dependent Apps Suspended
Individuals filing Form I-539 to request an extension of or change of status to H-4, L-2, E-1, E-2, or E-3 nonimmigrant status will not need to submit the $85 biometric services fee or attend a biometrics appointment, provided the application submitted by September 30, 2023.
Source: natlawreview.com
USCIS Bundles Adjudications for H-4 L-2 EAD Applications for Dependents
Department of Homeland Security DHS reached settlement agreement in Edakunni v Mayorkas matter challenging Citizenship and Immigration Services USCIS over lengthy processing delays for applications extend dependent H-4 or L-2 status and Employment Authorization Document EAD.
Source: natlawreview.com
EAD H-4 and L-2 Applications and Principal's Petition Bundled
U.S. Citizenship and Immigration Services has entered into settlement agreement to bundle an application to extend or change H-4 or L-2 status and employment authorization document EAD application. Form I-539 is the application to extend/change nonimmigrant temporary status.
Source: natlawreview.com